Literature DB >> 9473348

Contribution of protein kinase C to p53-dependent WAF1 induction pathway after heat treatment in human glioblastoma cell lines.

K Ohnishi1, X Wang, A Takahashi, T Ohnishi.   

Abstract

To examine whether protein kinase C (PKC) contributes to p53-dependent WAF1 induction after heat treatment, the effects of calphostin C (CAL), a specific inhibitor of PKC, on WAF1 induction were analyzed by PKC activity and gel mobility-shift assays and Western blot analysis in human glioblastoma cell lines. Heat-induced accumulation of WAF1 in A-172 cells carrying wild-type p53 (wtp53) was suppressed by CAL in a dose-dependent manner. In T98G cells carrying mutant p53 (mp53), no significant accumulation of WAF1 was observed after heat treatment and CAL exerted no significant effects on this response of T98G cells. In accordance with the accumulation of WAF1, heat-induced activation of the binding ability of p53 to p53 consensus sequence (p53 CON) was suppressed by CAL in A-172 cells but no DNA-binding activity was observed in the mp53 in T98G cells. PKC in A-172 cells was activated rapidly (within 5 min) after heat treatment in the membrane fraction but not in the cytosolic fraction. When the cell lines were treated with the PKC activator, 12-O-tetradecanoyl-phorbol-13-acetate (TPA), WAF1 was accumulated in A-172 cells in a dose-dependent manner but not in T98G cells. In addition, the cellular contents of WAF1 after heating did not increase in A-172 cells transformed with mp53. These results suggest that PKC contributes to heat-induced signal transduction leading to p53-dependent WAF1 induction in a way that PKC is involved in the specific DNA-binding activation of p53. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9473348     DOI: 10.1006/excr.1997.3842

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  7 in total

1.  Glycerol restores heat-induced p53-dependent apoptosis of human glioblastoma cells bearing mutant p53.

Authors:  Takeo Ohnishi; Ken Ohnishi; Akihisa Takahashi
Journal:  BMC Biotechnol       Date:  2002-04-19       Impact factor: 2.563

2.  Glycerol restores p53-dependent radiosensitivity of human head and neck cancer cells bearing mutant p53.

Authors:  K Ohnishi; I Ota; A Takahashi; T Ohnishi
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

3.  Impact of the p53 status of the tumor cells on the effect of reactor neutron beam irradiation, with emphasis on the response of intratumor quiescent cells.

Authors:  Shin-ichiro Masunaga; Koji Ono; Akihisa Takahashi; Yoshinori Sakurai; Ken Ohnishi; Toru Kobayashi; Yuko Kinashi; Masao Takagaki; Takeo Ohnishi
Journal:  Jpn J Cancer Res       Date:  2002-12

4.  Radiosensitivity and Capacity to Recover from Radiation-Induced Damage in Pimonidazole-Unlabeled Intratumor Quiescent Cells Depend on p53 Status.

Authors:  Shin-Ichiro Masunaga; Yong Liu; Hiroki Tanaka; Yoshinori Sakurai; Minoru Suzuki; Natsuko Kondo; Akira Maruhashi; Koji Ono
Journal:  World J Oncol       Date:  2011-02-26

5.  Effects of p53 Status of Tumor Cells and Combined Treatment With Mild Hyperthermia, Wortmannin or Caffeine on Recovery From Radiation-Induced Damage.

Authors:  Shin-Ichiro Masunaga; Keizo Tano; Yu Sanada; Minoru Suzuki; Akihisa Takahashi; Ken Ohnishi; Koji Ono
Journal:  World J Oncol       Date:  2019-06-29

6.  The Effect of p53 Status of Tumor Cells on Radiosensitivity of Irradiated Tumors With Carbon-Ion Beams Compared With γ-Rays or Reactor Neutron Beams.

Authors:  Shin-Ichiro Masunaga; Akiko Uzawa; Ryoichi Hirayama; Yoshitaka Matsumoto; Yoshinori Sakurai; Hiroki Tanaka; Keizo Tano; Yu Sanada; Minoru Suzuki; Akira Maruhashi; Koji Ono
Journal:  World J Oncol       Date:  2015-08-27

7.  The Effect of p53 Status on Radio-Sensitivity of Quiescent Tumor Cell Population Irradiated With γ-Rays at Various Dose Rates.

Authors:  Shin-Ichiro Masunaga; Junya Kobayashi; Keizo Tano; Yu Sanada; Minoru Suzuki; Koji Ono
Journal:  J Clin Med Res       Date:  2018-10-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.